Azenta, Inc. AZTA
Nasdaq · XNAS · stock · Special Industry Machinery, NEC
Chart by TradingView
6/9
Piotroski F — financial health
9.11
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $593.8M | -$55.8M | $270.3M | $38.3M | $1.7B |
| 2024 | $573.4M | -$164.9M | $254.6M | $12.4M | $1.8B |
| 2023 | $551.5M | -$14.6M | $239.2M | -$33.6M | $2.5B |
| 2022 | $555.5M | $2.1B | $255.6M | -$539.5M | $3.4B |
| 2021 | $513.7M | $110.7M | $243.8M | $97.1M | $1.3B |
| 2020 | $388.5M | $64.9M | $172.1M | -$2.1M | $1.2B |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Cornog William L | director | 2026-05-18 | Buy | 10,000 | $16.38 |
| Starr Ephraim | SVP, Gen Counsel & Secretary | 2026-05-15 | Tax withheld | 3,621 | $16.02 |
| MARTIN WILLIAM E. III | President Multiomics | 2026-04-28 | Grant | 17,790 | $24.24 |
| Nova Tina Susan | director | 2026-02-06 | Grant | 5,663 | $27.85 |
| Koffey Quentin | director | 2026-02-05 | Grant | 5,663 | — |
| Doshi Dipal | director | 2026-02-05 | Grant | 5,663 | $27.85 |
| Casal Frank | director | 2026-02-05 | Grant | 7,243 | $27.85 |
| McLaughlin Erica | director | 2026-02-05 | Grant | 5,663 | $27.85 |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 9.11 (safe)
- Working capital / assets 0.229
- Retained earnings / assets 0.689
- EBIT / assets -0.013
- Equity / liabilities 5.192
Source: SEC EDGAR filings · CIK 0000933974 · as of 2025-09-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.